ScandiDos Announces Delta4 Discover™ Launch Plans At ASTRO Meeting

Today at the American Society for Radiation Oncology (ASTRO) 56th Annual Meeting, ScandiDos AB [NASDAQ OMX First North: SDOS] announced its plans for launching Delta4 Discover™, a new product in its successful Delta4 dosimetry equipment platform. ScandiDos, worldwide leader in the development of advanced dosimetry and QA (Quality Assurance) products for cancer radiation therapy, said it has made excellent progress in Delta4 Discover’s development and expects to be able to launch it in the U.S. within the next few months, pending finalization of beta testing and FDA approval.

Help employers find you! Check out all the jobs and post your resume.